Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Phase II AutoImmune Hepatitis
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Christopher O'Brien, MD
- Registration Number
- NCT03593460
Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies
Phase 2
Withdrawn
- Conditions
- Panel Reactive Antibodies
- Interventions
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Christopher O'Brien, MD
- Registration Number
- NCT03593421
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Christopher O'Brien, MD
- Target Recruit Count
- 36
- Registration Number
- NCT02239562
- Locations
- 🇺🇸
Center for Liver Diseases; University of Miami, Miami, Florida, United States
🇺🇸Chief Scientist, BIOINCEPT, LLC / Chairman, (SIEP) / Director, Ob&Gyn CAMcare Health Center, Cherry Hill, New Jersey, United States
News
No news found